These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6730783)

  • 21. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of spiramycin in murine models of acute and chronic toxoplasmosis.
    Grujić J; Djurković-Djaković O; Nikolić A; Klun I; Bobić B
    Int J Antimicrob Agents; 2005 Mar; 25(3):226-30. PubMed ID: 15737517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Could miltefosine be used as a therapy for toxoplasmosis?
    Eissa MM; Barakat AM; Amer EI; Younis LK
    Exp Parasitol; 2015 Oct; 157():12-22. PubMed ID: 26112396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of spiramycin against Toxoplasma gondii in vitro, in experimental infections and in human infection.
    Chang HR; Pechère JC
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():87-92. PubMed ID: 3182450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic infection with Toxoplasma gondii does not prevent acute disease or colonization of the brain with tissue cysts following reinfection with different strains of the parasite.
    Araujo F; Slifer T; Kim S
    J Parasitol; 1997 Jun; 83(3):521-2. PubMed ID: 9194838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of the initial site of Toxoplasma gondii reactivation in brain tissue.
    Takashima Y; Suzuki K; Xuan X; Nishikawa Y; Unno A; Kitoh K
    Int J Parasitol; 2008 Apr; 38(5):601-7. PubMed ID: 18022177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An ultrastructural study of the effect of treatment with atovaquone in brains of mice chronically infected with the ME49 strain of Toxoplasma gondii.
    Ferguson DJ; Huskinson-Mark J; Araujo FG; Remington JS
    Int J Exp Pathol; 1994 Apr; 75(2):111-6. PubMed ID: 8199003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oocyst-induced murine toxoplasmosis: life cycle, pathogenicity, and stage conversion in mice fed Toxoplasma gondii oocysts.
    Dubey JP; Speer CA; Shen SK; Kwok OC; Blixt JA
    J Parasitol; 1997 Oct; 83(5):870-82. PubMed ID: 9379292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Infectivity of low numbers of Toxoplasma gondii oocysts to pigs.
    Dubey JP; Lunney JK; Shen SK; Kwok OC; Ashford DA; Thulliez P
    J Parasitol; 1996 Jun; 82(3):438-43. PubMed ID: 8636849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketolide ABT-773 is active against Toxoplasma gondii.
    Khan AA; Araujo FG; Craft JC; Remington JS
    J Antimicrob Chemother; 2000 Sep; 46(3):489-92. PubMed ID: 10980181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Separation of toxoplasma cysts from brain tissue and liberation of viable bradyzoites.
    Freyre A
    J Parasitol; 1995 Dec; 81(6):1008-10. PubMed ID: 8544039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parasitemia and tissue infection in sheep fed Toxoplasma gondii oocysts.
    Dubey JP; Sharma SP
    J Parasitol; 1980 Feb; 66(1):111-4. PubMed ID: 7365627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An immunohistochemical method for detecting bradyzoite antigen (BAG5) in Toxoplasma gondii-infected tissues cross-reacts with a Neospora caninum bradyzoite antigen.
    McAllister MM; Parmley SF; Weiss LM; Welch VJ; McGuire AM
    J Parasitol; 1996 Apr; 82(2):354-5. PubMed ID: 8604117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of sulfamethoxazole on murine ocular toxoplasmosis in interferon-gamma knockout mice.
    Norose K; Aosai F; Mun HS; Yano A
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):265-71. PubMed ID: 16384972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy of experimental toxoplasmosis with special reference to robenidine.
    Bakhtari SK; Jíra J
    Folia Parasitol (Praha); 1988; 35(3):193-8. PubMed ID: 2974008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spiramycin-loaded maltodextrin nanoparticles as a promising treatment of toxoplasmosis on murine model.
    Abdel-Wahab AA; Shafey DA; Selim SM; Sharaf SA; Mohsen KK; Allam DM; Elkhadry SW; Gouda MA
    Parasitol Res; 2024 Jul; 123(7):286. PubMed ID: 39046555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of Nigella sativa oil on experimental toxoplasmosis.
    Mady RF; El-Hadidy W; Elachy S
    Parasitol Res; 2016 Jan; 115(1):379-90. PubMed ID: 26446086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colchicine decreases the infection by Toxoplasma gondii in cultured glial cells.
    Aguirre-Cruz L; Calderon M; Sotelo J
    J Parasitol; 1996 Apr; 82(2):325-7. PubMed ID: 8604106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii.
    Romand S; Della Bruna C; Farinotti R; Derouin F
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2015-20. PubMed ID: 8878573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of chemo-immunotherapy with SDDS, pyrimethamine and anti-toxoplasma serum on toxoplasma gondii cysts in latent infected NMRI mice.
    Werner H; Masihi KN; Tischer I; Adusu E
    Tropenmed Parasitol; 1977 Dec; 28(4):528-32. PubMed ID: 601857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.